Effects of proton pump inhibitors on serum and fecal biomarkers and intestinal microbiota in dogs
PLOS One · 20.11.2026 · 21 (11) · e0361194
DOI: 10.1371/journal.pone.0361194 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.11.2026. Verfasst von Felipe Saab Romano und 6 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAPES.
Abstract (Originalsprache)
The gastrointestinal tract of mammals, including dogs and cats, is inhabited by a highly diverse intestinal microbiota that plays an essential role in both health and disease. This microbial ecosystem influences various processes such as metabolism, immunity, neurodevelopment, and the maintenance of homeostasis and can be altered in many circumstances such as diseases, the use of oral medications and gastrointestinal pH. Proton Pump Inhibitors are suspected of causing dysbiosis due to the alteration of gastric pH. This study evaluated the effects PPIs on the microbiota of healthy dogs. Twenty Golden Retrievers were randomly allocated into four treatment groups (n = 5 per group): Omeprazole (OMP – 1 mg/kg twice a day), Esomeprazole (ESO – 1 mg/kg twice a day), Lansoprazole (LSP – 0.5 mg/kg twice a day), and Control (Placebo, CTL) and treated for 30 days. Feces were collected at the beginning (T0) and end (T30) of the trial for evaluation of dysbiosis index and blood biochemistry was performed to quantify target variables of gastrointestinal diseases (folate, cobalamin, iron and calcium) at the same period. Gastrin serum concentrations were evaluated at T0 and T30 only for the LSP group. Results showed no clinical signs or changes in the global dysbiosis index among treatments. However, specific microbial alterations were observed, including a reduction in Turicibacter in the OMP and ESO groups, and an increase in Streptococcus spp. in few individuals in the OMP group. Serum biomarkers related to inflammation and gastrointestinal absorption remained unchanged. In this study, PPIs did not induce intestinal dysbiosis or caused any clinical impairment, although some isolated microbial changes were noted.
Förderung
- CAPES
Zitieren
APA
Romano, F. S., Barbosa, I. S., Melchert, A., Amaral, A. R., Vendramini, T. H. A., Suchodolski, J., & Lallo, M. A. (2026). Effects of proton pump inhibitors on serum and fecal biomarkers and intestinal microbiota in dogs. PLOS One, 21(11), e0361194. https://doi.org/10.1371/journal.pone.0361194
Vancouver
Romano FS, Barbosa IS, Melchert A, Amaral AR, Vendramini THA, Suchodolski J, et al. Effects of proton pump inhibitors on serum and fecal biomarkers and intestinal microbiota in dogs. PLOS One. 2026;21(11):e0361194. doi:10.1371/journal.pone.0361194
BibTeX
@article{Romano2026,
author = {Romano, Felipe Saab and Barbosa, Ivana Suffredini and Melchert, Alessandra and Amaral, Andressa Rodrigues and Vendramini, Thiago Henrique Annibale and Suchodolski, Jan and Lallo, Maria Anete},
title = {Effects of proton pump inhibitors on serum and fecal biomarkers and intestinal microbiota in dogs},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361194},
doi = {10.1371/journal.pone.0361194}
}
EUVIMED